rs55698160

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_177550.5(SLC13A5):​c.1092C>T​(p.Ala364Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0871 in 1,612,512 control chromosomes in the GnomAD database, including 6,722 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.090 ( 676 hom., cov: 32)
Exomes 𝑓: 0.087 ( 6046 hom. )

Consequence

SLC13A5
NM_177550.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.141

Publications

10 publications found
Variant links:
Genes affected
SLC13A5 (HGNC:23089): (solute carrier family 13 member 5) This gene encodes a protein belonging to the solute carrier family 13 group of proteins. This family member is a sodium-dependent citrate cotransporter that may regulate metabolic processes. Mutations in this gene cause early infantile epileptic encephalopathy 25. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2014]
SLC13A5 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 25
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • amelocerebrohypohidrotic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • pyridoxine-dependent epilepsy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.68).
BP6
Variant 17-6694161-G-A is Benign according to our data. Variant chr17-6694161-G-A is described in ClinVar as Benign. ClinVar VariationId is 380900.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.141 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.114 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC13A5NM_177550.5 linkc.1092C>T p.Ala364Ala synonymous_variant Exon 8 of 12 ENST00000433363.7 NP_808218.1 Q86YT5-1Q68D44

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC13A5ENST00000433363.7 linkc.1092C>T p.Ala364Ala synonymous_variant Exon 8 of 12 1 NM_177550.5 ENSP00000406220.2 Q86YT5-1

Frequencies

GnomAD3 genomes
AF:
0.0898
AC:
13659
AN:
152090
Hom.:
674
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.117
Gnomad AMI
AF:
0.0385
Gnomad AMR
AF:
0.0630
Gnomad ASJ
AF:
0.0147
Gnomad EAS
AF:
0.00365
Gnomad SAS
AF:
0.0461
Gnomad FIN
AF:
0.0848
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.0951
Gnomad OTH
AF:
0.0793
GnomAD2 exomes
AF:
0.0691
AC:
17271
AN:
249990
AF XY:
0.0682
show subpopulations
Gnomad AFR exome
AF:
0.115
Gnomad AMR exome
AF:
0.0372
Gnomad ASJ exome
AF:
0.0137
Gnomad EAS exome
AF:
0.00578
Gnomad FIN exome
AF:
0.0846
Gnomad NFE exome
AF:
0.0917
Gnomad OTH exome
AF:
0.0660
GnomAD4 exome
AF:
0.0868
AC:
126702
AN:
1460304
Hom.:
6046
Cov.:
30
AF XY:
0.0850
AC XY:
61721
AN XY:
726452
show subpopulations
African (AFR)
AF:
0.117
AC:
3914
AN:
33378
American (AMR)
AF:
0.0398
AC:
1775
AN:
44654
Ashkenazi Jewish (ASJ)
AF:
0.0143
AC:
373
AN:
26126
East Asian (EAS)
AF:
0.0102
AC:
403
AN:
39662
South Asian (SAS)
AF:
0.0420
AC:
3614
AN:
86086
European-Finnish (FIN)
AF:
0.0893
AC:
4762
AN:
53350
Middle Eastern (MID)
AF:
0.0234
AC:
135
AN:
5768
European-Non Finnish (NFE)
AF:
0.0960
AC:
106693
AN:
1110936
Other (OTH)
AF:
0.0834
AC:
5033
AN:
60344
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
4938
9876
14814
19752
24690
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3816
7632
11448
15264
19080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0898
AC:
13670
AN:
152208
Hom.:
676
Cov.:
32
AF XY:
0.0861
AC XY:
6405
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.117
AC:
4844
AN:
41522
American (AMR)
AF:
0.0628
AC:
961
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.0147
AC:
51
AN:
3472
East Asian (EAS)
AF:
0.00366
AC:
19
AN:
5188
South Asian (SAS)
AF:
0.0466
AC:
225
AN:
4830
European-Finnish (FIN)
AF:
0.0848
AC:
899
AN:
10600
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.0951
AC:
6468
AN:
67984
Other (OTH)
AF:
0.0780
AC:
165
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
644
1288
1933
2577
3221
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
154
308
462
616
770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0853
Hom.:
574
Bravo
AF:
0.0878
Asia WGS
AF:
0.0440
AC:
155
AN:
3478
EpiCase
AF:
0.0820
EpiControl
AF:
0.0798

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Apr 20, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Developmental and epileptic encephalopathy, 25 Benign:2
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Jan 12, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Inborn genetic diseases Benign:1
Apr 11, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.68
CADD
Benign
7.8
DANN
Benign
0.56
PhyloP100
0.14
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=95/5
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs55698160; hg19: chr17-6597480; COSMIC: COSV53425091; COSMIC: COSV53425091; API